https://de.marketscreener.com/kurs/aktie/ROCHE-HOLDING-AG-68997/news/Roche-vermeldet-positive-Studiendaten-zu-Mittel-Entrectinib-28604349/?utm_source=telegram&utm_medium=social&utm_campaign=share